Table 5.
Comparing the proposed review against previous reviews on joint DR and CVD.
| Citations | Year | DR a | CVD b | RI c | CI d | AI e | RS f | COV-19 g |
|---|---|---|---|---|---|---|---|---|
| Son et al. [22] | 2010 | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Alonso et al. [37] | 2015 | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Ting et al. [26] | 2019 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Simó et al. [38] | 2019 | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✕ |
| Gupta et al. [39] | 2021 | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✕ |
| Proposed Review | 2022 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
DR a: Diabetic Retinopathy: CVD b: Cardiovascular Diseases, RI c: Retinal Imaging, CI d: Carotid Imaging AI e: Artificial Intelligence, RS f: Risk Stratification, COV-19 g: COVID-19.